436 related articles for article (PubMed ID: 36142615)
1. Immune Tumor Microenvironment in Ovarian Cancer Ascites.
Almeida-Nunes DL; Mendes-Frias A; Silvestre R; Dinis-Oliveira RJ; Ricardo S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142615
[TBL] [Abstract][Full Text] [Related]
2. Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.
Rakina M; Kazakova A; Villert A; Kolomiets L; Larionova I
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682890
[TBL] [Abstract][Full Text] [Related]
3. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ; Telleria CM
Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025
[TBL] [Abstract][Full Text] [Related]
4. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
5. Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.
Finkernagel F; Reinartz S; Schuldner M; Malz A; Jansen JM; Wagner U; Worzfeld T; Graumann J; von Strandmann EP; Müller R
Theranostics; 2019; 9(22):6601-6617. PubMed ID: 31588238
[TBL] [Abstract][Full Text] [Related]
6. Association between effector-type regulatory T cells and immune checkpoint expression on CD8
Sato S; Matsushita H; Shintani D; Kobayashi Y; Fujieda N; Yabuno A; Nishikawa T; Fujiwara K; Kakimi K; Hasegawa K
BMC Cancer; 2022 Apr; 22(1):437. PubMed ID: 35449092
[TBL] [Abstract][Full Text] [Related]
7. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
[TBL] [Abstract][Full Text] [Related]
8. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
[TBL] [Abstract][Full Text] [Related]
9. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.
Auer K; Bachmayr-Heyda A; Sukhbaatar N; Aust S; Schmetterer KG; Meier SM; Gerner C; Grimm C; Horvat R; Pils D
Oncotarget; 2016 Sep; 7(38):61336-61354. PubMed ID: 27665539
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
[TBL] [Abstract][Full Text] [Related]
11. Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites.
Hrvat A; Schmidt M; Wagner B; Zwanziger D; Kimmig R; Volbracht L; Brandau S; Mallmann-Gottschalk N
J Exp Clin Cancer Res; 2023 Sep; 42(1):235. PubMed ID: 37684704
[TBL] [Abstract][Full Text] [Related]
12. Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.
Carduner L; Leroy-Dudal J; Picot CR; Gallet O; Carreiras F; Kellouche S
Clin Exp Metastasis; 2014 Aug; 31(6):675-88. PubMed ID: 24946950
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.
Vyhlídalová Kotrbová A; Gömöryová K; Mikulová A; Plešingerová H; Sladeček S; Kravec M; Hrachovinová Š; Potěšil D; Dunsmore G; Blériot C; Bied M; Kotouček J; Bednaříková M; Hausnerová J; Minář L; Crha I; Felsinger M; Zdráhal Z; Ginhoux F; Weinberger V; Bryja V; Pospíchalová V
J Extracell Vesicles; 2024 Mar; 13(3):e12420. PubMed ID: 38490958
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
K Au K; Peterson N; Truesdell P; Reid-Schachter G; Khalaj K; Ren R; Francis JA; Graham CH; Craig AW; Koti M
Gynecol Oncol; 2017 Jun; 145(3):436-445. PubMed ID: 28318643
[TBL] [Abstract][Full Text] [Related]
16. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer.
Asem M; Young A; Oyama C; ClaureDeLaZerda A; Liu Y; Ravosa MJ; Gupta V; Jewell A; Khabele D; Stack MS
Sci Rep; 2020 Jul; 10(1):11913. PubMed ID: 32681052
[TBL] [Abstract][Full Text] [Related]
17. Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis.
Tseng SH; Park ST; Lam B; Tsai YC; Cheng MA; Farmer E; Xing D; Hung CF
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32111730
[TBL] [Abstract][Full Text] [Related]
18. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.
Kim S; Kim B; Song YS
Cancer Sci; 2016 Sep; 107(9):1173-8. PubMed ID: 27297561
[TBL] [Abstract][Full Text] [Related]
19. Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.
Monavarian M; Elhaw AT; Tang PW; Javed Z; Shonibare Z; Scalise CB; Arend R; Jolly MK; Sewell-Loftin MK; Hempel N; Mythreye K
Semin Cancer Biol; 2022 Nov; 86(Pt 2):709-719. PubMed ID: 35259492
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]